To determine whether these oncogenic RIT1 dependencies extended to other cell contexts and in the absence of erlotinib treatment, we evaluated their function in NCI-H2110, a RIT1M90I-mutant non-small cell lung cancer cell line7. Here, RIT1 is linked to non-small cell lung carcinoma.